Lexaria Bioscience (LEXX) Inventory (2014 - 2023)
Lexaria Bioscience (LEXX) posted Inventory of $7588.0 for Q1 2023, down 23.63% sequentially from $9936.0 in Q4 2022, and down 76.23% YoY from $31927.0 in Q1 2022.
Lexaria Bioscience (LEXX) Inventory (2014 - 2023) Analysis & Trends
Lexaria Bioscience has reported Inventory for 10 years, with the latest figure at $7588.0 in Q1 2023.
- Quarterly Inventory fell 76.23% year-over-year to $7588.0 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was $7588.0 (down 76.23% YoY) and the FY2022 annual result came in at $38418.0, up 29.58% from the prior year.
- Inventory eased to $7588.0 in Q1 2023 per LEXX's latest filing, from $9936.0 in the prior quarter.
- Over five years, Inventory peaked at $188275.0 in Q2 2019 and troughed at -$6067.0 in Q4 2020.
- A 5-year average of $75001.1 and a median of $51738.0 in 2021 frame the typical range for Inventory.
- The sharpest annual moves came in 2020 and 2022: Inventory sank 104.54% in 2020, then soared 240.97% in 2022.
- Over 5 years, Inventory stood at $133556.0 in 2019, then tumbled by 104.54% to -$6067.0 in 2020, then soared by 148.03% to $2914.0 in 2021, then jumped by 240.97% to $9936.0 in 2022, then decreased by 23.63% to $7588.0 in 2023.
- According to Business Quant data, Inventory over the past three periods registered $7588.0, $9936.0, and $38418.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2023 | 7,588.00 |
| Nov 30, 2022 | 9,936.00 |
| Aug 31, 2022 | 38,418.00 |
| May 31, 2022 | 40,183.00 |
| Feb 28, 2022 | 31,927.00 |
| Nov 30, 2021 | 2,914.00 |
| Aug 31, 2021 | 29,648.00 |
| May 31, 2021 | 51,738.00 |
| Feb 28, 2021 | 137,282.00 |
| Nov 30, 2020 | -6,067.00 |
| Aug 31, 2020 | 116,871.00 |
| May 31, 2020 | 132,923.00 |
| Feb 29, 2020 | 124,412.00 |
| Nov 30, 2019 | 133,556.00 |
| Aug 31, 2019 | 127,396.00 |
| May 31, 2019 | 188,275.00 |
| Feb 28, 2019 | 108,018.00 |
| Nov 30, 2018 | 116,668.00 |
| Aug 31, 2018 | 87,233.00 |
| May 31, 2018 | 76,475.00 |